Autoimmune Hemolytic Anemia After Cord Blood Transplantation: A Retrospective Single-Center Experience

References

• Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122(4):491–498. doi:10.1182/blood-2013-02-453175
   PubMed Web of Science ®Google Scholar
• Doan PL, Chao NJ. Umbilical cord blood: biology and transplantation. Expert Rev Hematol. 2009;2(2):197–208. doi:10.1586/ehm.09.9
   PubMed Web of Science ®Google Scholar
• Faraci M, Dell’Orso G, Giardino S, Pierri F. Autoimmune diseases after allogeneic stem cell transplantation: a clinician’s guide and future outlook. Expert Rev Clin Immunol. 2022;12:1–14.
   Google Scholar
• Michniacki TF, Ebens CL, Choi SW. Immune-mediated cytopenias after hematopoietic cell transplantation: pathophysiology, clinical manifestations, diagnosis, and treatment strategies. Curr Oncol Rep. 2019;21(10):87. doi:10.1007/s11912-019-0838-7
   PubMed Web of Science ®Google Scholar
• Page KM, Mendizabal AM, Prasad VK, et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2008;14(10):1108–1117. doi:10.1016/j.bbmt.2008.07.006
   PubMed Web of Science ®Google Scholar
• Chen RL, Wu PL, Hsu YH, Kuo PL. Evans syndrome after unrelated cord blood transplantation for disseminated Langerhans cell histiocytosis in a child. J Pediatr Hematol Oncol. 2007;29(5):348–350. doi:10.1097/MPH.0b013e3180556467
   Web of Science ®Google Scholar
• Daikeler T, Labopin M, Ruggeri A, et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2013;121(6):1059–1064. doi:10.1182/blood-2012-07-445965
   PubMed Web of Science ®Google Scholar
• Sanz J, Arango M, Carpio N, et al. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience. Bone Marrow Transplant. 2014;49(8):1084–1088. doi:10.1038/bmt.2014.107
   Web of Science ®Google Scholar
• Jacobson CA, Turki AT, McDonough SM, et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biology of Blood and Marrow Transplantation. 2012;18:565–574. doi:10.1016/j.bbmt.2011.08.018
   PubMed Web of Science ®Google Scholar
• Gluckman E. Milestones in umbilical cord blood transplantation. Blood Rev. 2011;25(6):255–259. doi:10.1016/j.blre.2011.06.003
   PubMed Web of Science ®Google Scholar
• Wang Q, Ren H, Liang Z, et al. Comparable outcomes in acquired severe aplastic anemia patients with haploidentical donor or matched related donor transplantation: a retrospective single-center experience. Front Med. 2022;8:807527. doi:10.3389/fmed.2021.807527
   Web of Science ®Google Scholar
• Zhang XH, Chen J, Han MZ, et al. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol. 2021;14(1):145. doi:10.1186/s13045-021-01159-2
   PubMed Web of Science ®Google Scholar
• Yin Y, Ren HY, Cen XA, et al. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units. Chin Med J. 2011;124(16):2411–2416.
   Web of Science ®Google Scholar
• Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648. doi:10.1016/j.blre.2019.100648
   PubMed Web of Science ®Google Scholar
• Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829–3866. doi:10.1182/bloodadvances.2019000966
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393. doi:10.1182/blood-2008-07-162503
   PubMed Web of Science ®Google Scholar
• González-Vicent M, Sanz J, Fuster JL, et al. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): a retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfus Med Rev. 2018;S0887-7963(17)30164–5. doi:10.1016/j.tmrv.2018.02.005
   Web of Science ®Google Scholar
• O’Brien TA, Eastlund T, Peters C, et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol. 2004;127(1):67–75. doi:10.1111/j.1365-2141.2004.05138.x
   PubMed Web of Science ®Google Scholar
• Godder K, Pati AR, Abhyankar SH, Lamb LS, Armstrong W, Henslee-Downey PJ. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant. 1997;19(8):813–817. doi:10.1038/sj.bmt.1700746
   Web of Science ®Google Scholar
• Yang Z, Wu B, Zhou Y, et al. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation. Chin Med J. 2014;127(7):1235–1238.
   PubMed Web of Science ®Google Scholar
• Park JA, Lee HH, Kwon HS, Baik CR, Song SA, Lee JN. Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of post-transplant autoimmune hemolytic anemia. Transfus Med Rev. 2016;30(1):6–14. doi:10.1016/j.tmrv.2015.09.001
   PubMed Web of Science ®Google Scholar